ARTICLE
22 May 2025

CMMI's New Strategic Direction: What To Know

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Following the announcement that four Center for Medicare and Medicaid Innovation (CMMI or Innovation Center) models will end in 2025, the Centers for Medicare & Medicaid Services...
United States Food, Drugs, Healthcare, Life Sciences

Following the announcement that four Center for Medicare and Medicaid Innovation (CMMI or Innovation Center) models will end in 2025, the Centers for Medicare & Medicaid Services (CMS) has begun signaling what's next for the Innovation Center. Last week, CMMI Director Abe Sutton and CMS Administrator Dr. Mehmet Oz outlined a new strategic direction built around several core pillars.

Though not a fully developed strategy, the new framework offers insight into the types of models CMMI may pursue. Key focus areas include:

  • advancing evidence-based prevention
  • expanding model activity in Medicare Advantage, Medicaid and drug pricing
  • prioritizing cost savings and financial accountability
  • increasing access to consumer-facing tools and data
  • supporting independent and rural providers
  • promoting choice and competition

Emphasis on Savings

CMMI is now placing a stronger emphasis on generating cost savings. The administration appears to view models that do not reduce costs as falling short of expectations.

Shift Toward Mandatory Participation

Sutton suggested CMMI may increasingly use its authority to require participation in new models – marking a significant shift from the largely voluntary approach taken to date. Currently, mandatory models are limited, with the Transforming Episode Accountability Model (TEAM) being a rare example.

Increased Financial Risk for Physicians

Future physician-focused models are expected to include downside financial risk from the start. Sutton underscored the agency's goal of maximizing participation in value-based arrangements that include such risk.

What It Means for Stakeholders

Participants in current models should prepare for possible changes to model design and expansion to new populations. Attribution and beneficiary consent processes may need to be reworked to support broader, potentially mandatory participation.

CMMI also appears to be creating new opportunities for nontraditional providers, including artificial intelligence (AI) vendors and care management platforms. Streamlining quality reporting and aligning measurement efforts with the administration's deregulatory agenda could create space for these organizations to demonstrate value in future models.

More Information

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More